Cover Image

Pretreatment resistance mutations and treatment outcomes in adults living with HIV-1: a cohort study in urban Malawi

Pre-treatment drug resistance (PDR) among antiretroviral drug-naïve people living with HIV (PLHIV) represents an important indicator for the risk of treatment failure and the spread of drug resistant HIV variants. We assessed the prevalence of PDR and treatment outcomes among adults living with HIV...

Full description

Saved in:
Bibliographic Details
Main Authors: Neuhann, Florian (Author) , de Forest, A (Author) , Heger, E. (Author) , Nhlema, A. (Author) , Scheller, C. (Author) , Kaiser, R. (Author) , Steffen, H. M. (Author) , Tweya, H. (Author) , Fätkenheuer, G. (Author) , Phiri, S. (Author)
Format: Article (Journal)
Language:English
Published: 20 May 2020
In: AIDS research and therapy
Year: 2020, Volume: 17, Issue: 1, Pages: 1-7
ISSN:1742-6405
DOI:10.1186/s12981-020-00282-3
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12981-020-00282-3
Verlag, lizenzpflichtig, Volltext: https://aidsrestherapy.biomedcentral.com/articles/10.1186/s12981-020-00282-3
Get full text
Author Notes:F. Neuhann, A. de Forest, E. Heger, A. Nhlema, C. Scheller, R. Kaiser, H.M. Steffen, H. Tweya, G. Fätkenheuer and S. Phiri
Description
Summary:Pre-treatment drug resistance (PDR) among antiretroviral drug-naïve people living with HIV (PLHIV) represents an important indicator for the risk of treatment failure and the spread of drug resistant HIV variants. We assessed the prevalence of PDR and treatment outcomes among adults living with HIV-1 in Lilongwe, Malawi.
Item Description:Gesehen am 31.03.2021
Physical Description:Online Resource
ISSN:1742-6405
DOI:10.1186/s12981-020-00282-3

Similar Items